In this episode, we pull back the curtain on Cencora, the company formerly known as AmerisourceBergen. Despite handling nearly 20% of all pharmaceuticals sold in the United States, this industry titan often operates behind the scenes. We trace its origins from the 2001 merger of AmeriSource and Bergen Brunswig to its evolution into a global powerhouse with over $300 billion in annual revenue.

We dig deep into the controversies that have plagued the distributor, including its central role in the American Opioid Epidemic, which led to a historic $26 billion settlement with states and local governments. You’ll hear about the "PFS Program," a civil fraud scheme involving the repackaging of cancer drugs that resulted in an $885 million payout, and the company's unusual agreement with the U.S. government to distribute Remdesivir during the early  ...